000220.KS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 14:30):

Stats
今日成交量	37 530.00
平均成交量	154 849
市值	76.38B
EPS	KRW0 ( 2023-09-30 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW6.14 (0.13%)

音量相关性

長: 0.06 (neutral)

短: -0.88 (strong negative)

Signal:(60.358) Neutral

Yuyu Pharma, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Yuyu Pharma, Inc. 相关性 - 货币/商品

-0.85
( strong negative )

-0.74
( moderate negative )

-0.80
( moderate negative )

-0.67
( moderate negative )

0.02
( neutral )

0.76
( moderate )

Yuyu Pharma, Inc. 财务报表

Annual	2023
营收:	KRW137.21B
毛利润:	KRW46.51B (33.89 %)
EPS:	KRW-441.41

FY	2023
营收:	KRW137.21B
毛利润:	KRW46.51B (33.89 %)
EPS:	KRW-441.41

FY	2022
营收:	KRW138.88B
毛利润:	KRW53.31B (38.39 %)
EPS:	KRW-266.90

FY	2021
营收:	KRW115.66B
毛利润:	KRW45.34B (39.20 %)
EPS:	KRW-21.10

Financial Reports:

No articles found.

Yuyu Pharma, Inc.

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.